Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine

RATIONALE: There are currently no data supporting specific dosing and weaning strategies for parenteral prostanoid therapy in children with pulmonary arterial hypertension (PAH). OBJECTIVES: To describe the clinical practice of intravenous (IV) or subcutaneous (SC) prostanoid therapy in pediatric PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Douwes, Johannes M., Zijlstra, Willemijn M. H., Rosenzweig, Erika B., Ploegstra, Mark-Jan, Krishnan, Usha S., Haarman, Meindina G., Roofthooft, Marcus T. R., Postmus, Douwe, Hillege, Hans L., Ivy, D. Dunbar, Berger, Rolf M. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867364/
https://www.ncbi.nlm.nih.gov/pubmed/34181866
http://dx.doi.org/10.1513/AnnalsATS.202012-1563OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867364/
https://www.ncbi.nlm.nih.gov/pubmed/34181866
http://dx.doi.org/10.1513/AnnalsATS.202012-1563OC

Ejemplares similares